Baioflow is a next-generation AI-biology platform that overcomes the blood-brain barrier (BBB) by discovering novel receptor targets through deep learning and applying them to antibody and biologic drug design. Unlike conventional AI models trained solely on theoretical or synthetic datasets, Baioflow is built on real-world experimental bio-data—enabling significantly higher reliability and translational relevance.

Baioflow generates validated experimental datasets of BBB-penetrating molecules, builds a specialized database, and trains AI models to learn from this real data. The AI then predicts ligands that are most suitable for delivery of antibody therapeutics across the BBB. This closed-loop platform enables rational ligand selection and improves CNS-targeted drug development success.